Nanoform’s transformation a year on from the IPO
A year on from Nanoform’s IPO in June 2020, we…
A year on from Nanoform’s IPO in June 2020, we…
We were pleased to host a session, “Overcoming Drug Development…
Our CCO, Christian Jones, FRSC, joined the Bio Integrates panel…
Overcoming Drug Development Challenges with Nanotechnology: Piroxicam, a commercially available…
We were excited to showcase the results from our collaboration…
Our Director of Pharmaceutical Development, Satu Lakio, gave a presentation…
Our Head of AI, Prof. Jukka Corander joined a panel…